Valoid 50mg/1ml solution for injection ampoules

Land: Vereinigtes Königreich

Sprache: Englisch

Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)

Wirkstoff:

Cyclizine lactate

Verfügbar ab:

Advanz Pharma

ATC-Code:

R06AE03

INN (Internationale Bezeichnung):

Cyclizine lactate

Dosierung:

50mg/1ml

Darreichungsform:

Solution for injection

Verabreichungsweg:

Intramuscular; Intravenous

Klasse:

No Controlled Drug Status

Verschreibungstyp:

Valid as a prescribable product

Produktbesonderheiten:

BNF: 04060000; GTIN: 5060064170236

Fachinformation

OBJECT 1
CYCLIZINE LACTATE 50 MG/ML INJECTION
Summary of Product Characteristics Updated 16-Nov-2015 | Concordia
International - formerly AMCo
1. Name of the medicinal product
Valoid 50 mg/ml Injection
Cyclizine Lactate 50 mg/ml Injection
2. Qualitative and quantitative composition
Each 1 ml ampoule contains 50 mg cyclizine lactate.
Excipients with known effect:
None
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Clear, colourless solution for injection.
4. Clinical particulars
4.1 Therapeutic indications
Valoid is indicated in adults for the prevention and treatment of
nausea and vomiting including:-
• Motion sickness when the oral route cannot be used.
• Nausea and vomiting caused by narcotic analgesics and by general
anaesthetics in the post-operative
period.
• Vomiting associated with radiotherapy especially for breast cancer
since cyclizine does not elevate
prolactin levels.
• Valoid injection, by the intravenous route, is also indicated
pre-operatively in patients undergoing
emergency surgery in order to reduce the hazard of regurgitation and
aspiration of gastric contents during
induction of general anaesthesia.
Valoid may be of value in relieving vomiting and attacks of vertigo
associated with Menière's disease and
other forms of vestibular disturbance when the oral route cannot be
used.
4.2 Posology and method of administration
Posology
For the prevention of postoperative nausea and vomiting, administer
the first dose by slow intravenous
injection 20 minutes before the anticipated end of surgery.
_Adults_
50 mg intramuscularly or intravenously up to three times daily.
When used intravenously, Valoid should be injected slowly into the
bloodstream, with only minimal
withdrawal of blood into the syringe.
For the prevention of postoperative nausea and vomiting, administer
the first dose by slow intravenous
injection 20 minutes before the anticipated end of surgery.
Cyclizine given intravenously, in half the recommended dose, increases
the lower oesophageal sphincter
tone and